GRDN (Guardian Pharmacy Services) Financial Strength: 9 (As of Jun. 2026) — 29% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRDN Guardian Pharmacy Services Inc GRDN
42 GF Score
Price $40.77
! 2 Warning Signs
View Full Analysis

What is Guardian Pharmacy Services Financial Strength?

Guardian Pharmacy Services GRDN +1.59% 42 Financial Strength is 9 as of Jun. 2026, which is 29% above its 10-year median of 7.00. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 2 warning signs investors should review.

Guardian Pharmacy Services has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Guardian Pharmacy Services Inc shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Guardian Pharmacy Services's Interest Coverage for the quarter that ended in Jun. 2026 was 134.05. Guardian Pharmacy Services's debt to revenue ratio for the quarter that ended in Jun. 2026 was 0.03. As of today, Guardian Pharmacy Services's Altman Z-Score is 12.81.


Guardian Pharmacy Services  (NYSE:GRDN) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Guardian Pharmacy Services has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.


Guardian Pharmacy Services Financial Strength Related Terms


GRDN vs MD, ADUS, ACHC: Financial Strength Comparison

For the Medical Care Facilities subindustry, Guardian Pharmacy Services's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardian Pharmacy Services Financial Strength vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's Financial Strength distribution charts can be found below:

* The bar in red indicates where Guardian Pharmacy Services's Financial Strength falls into.


GRDN
42GF Score
Guardian Pharmacy Services Inc GRDN
Financial Strength is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardian Pharmacy Services Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Guardian Pharmacy Services's Interest Expense for the months ended in Jun. 2026 was $-0 Mil. Its Operating Income for the months ended in Jun. 2026 was $21 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $28 Mil.

Guardian Pharmacy Services's Interest Coverage for the quarter that ended in Jun. 2026 is

Interest Coverage=-1*Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*20.644/-0.154
=134.05

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Guardian Pharmacy Services Inc has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Guardian Pharmacy Services's Debt to Revenue Ratio for the quarter that ended in Jun. 2026 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2026 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(7.375 + 27.863) / 1407.072
=0.03

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Guardian Pharmacy Services has a Z-score of 12.81, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 12.81 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Financial Strength →
What does a Financial Strength of 9 mean?
Guardian Pharmacy Services (GRDN) has a Financial Strength of 9 as of Jun. 2026. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Guardian Pharmacy Services and its competitors. This is 29% above median its historical median of 7.00. Over the past decade, Guardian Pharmacy Services' Financial Strength has ranged from 4.00 to 9.00.
Is Guardian Pharmacy Services' Financial Strength too high?
Guardian Pharmacy Services' current Financial Strength of 9 is 29% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Financial Strength compare to MD and ADUS?
Guardian Pharmacy Services' Financial Strength of 9 can be compared against companies in the Healthcare Providers & Services industry. Historically, Guardian Pharmacy Services' own Financial Strength has ranged from 4.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for a Healthcare Providers & Services company?
A good Financial Strength depends on the Healthcare Providers & Services industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Guardian Pharmacy Services and its competitors. Guardian Pharmacy Services's current Financial Strength is 9, which is 29% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Financial Strength of 9. The current Financial Strength is 9, which is 29% above median its 10-year median of 7.00. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Financial Strength is 9 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guardian Pharmacy Services Business Description

Address 300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score

Get the complete analysis for GRDN

Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.77
Price